France Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market Size & Outlook
Related Markets
France cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market highlights
- The France cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market generated a revenue of USD 267.5 million in 2024 and is expected to reach USD 506.9 million by 2035.
- The France market is expected to grow at a CAGR of 6.1% from 2025 to 2035.
- In terms of segment, cervical cancer screening was the largest revenue generating type in 2024.
- Cervical Cancer Screening is the most lucrative type segment registering the fastest growth during the forecast period.
Cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market data book summary
| Market revenue in 2024 | USD 267.5 million |
| Market revenue in 2035 | USD 506.9 million |
| Growth rate | 6.1% (CAGR from 2025 to 2035) |
| Largest segment | Cervical cancer screening |
| Fastest growing segment | Cervical Cancer Screening |
| Historical data | 2018 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2035 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Cervical Cancer Screening, Cervical Cancer Diagnostics, Pre-cancerous Lesion Treatment |
Other key industry trends
- In terms of revenue, France accounted for 3.2% of the global cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2035.
- In Europe, Germany cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market is projected to lead the regional market in terms of revenue in 2035.
- Germany is the fastest growing regional market in Europe and is projected to reach USD 926.2 million by 2035.
Cervical cancer screening was the largest segment with a revenue share of 51.48% in 2024. Horizon Databook has segmented the France cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market based on cervical cancer screening, cervical cancer diagnostics, pre-cancerous lesion treatment covering the revenue growth of each sub-segment from 2018 to 2035.
The French cervical cancer screening, diagnostics, and pre-cancerous dysplasia lesion treatment market is expanding in response to the disease’s incidence. Among the 27.9 million at-risk women, there are 3,379 new cases and 1,452 deaths annually.
Cervical cancer ranks 12th among female cancers and 4th for ages 15–44, with HPV-16/18 responsible for 75.6% of cases and a 4.7% HPV prevalence in women with normal cytology.
Since introducing HPV vaccination in 2007—with 46% receiving the first dose and 37% full-dose by 2021—France has also implemented a national screening program in 2020, targeting women aged 25–65 through cytology (every three years for ages 25–29) and HPV tests (every five years for ages 30–65), achieving a 76% participation rate over the past five years.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Scope
Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| MedGyn Products | View profile | 51-100 | Addison, Illinois, United States, North America | https://www.medgyn.com |
| Utah Medical Products Inc | View profile | 190 | 7043 South 300 West, Midvale, UT, United States, 84047 | http://www.utahmed.com |
| CooperSurgical | View profile | 501-1000 | Trumbull, Connecticut, United States, North America | http://www.coopersurgical.com |
| Hologic Inc | View profile | 6990 | 250 Campus Drive, Marlborough, MA, United States, 01752 | http://www.hologic.com |
| Qiagen NV | View profile | 5900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | https://www.qiagen.com |
| Becton Dickinson & Co | View profile | 73000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | https://www.bd.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Roche Holding AG ADR | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
France Type - Cervical Cancer Screening, Diagnostics, And Pre-cancerous Dysplasia Lesion Treatment Market size, 2024 - 2035 (US$M)
France Cervical Cancer Screening, Diagnostics, and Pre-cancerous Dysplasia Lesion Treatment Market Outlook Share, 2024 & 2035 (US$M)
Related industry reports
Related statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
